On the other hand, studies which enrolled participants with other metabolic aberrations in the setting of metabolic syndrome (MetS) reported that obese with MetS had higher serum OPG concentrations than controls [18, 31]. This evidence concerns the gene TNFRSF11B and metabolic syndrome.